These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 26510001)

  • 1. RECURRENT CENTRAL SEROUS CHORIORETINOPATHY ASSOCIATED WITH RETINITIS PIGMENTOSA TREATED WITH CARBONIC ANHYDRASE INHIBITORS.
    Pomykala M; Rubin P; Rubin JS
    Retin Cases Brief Rep; 2016; 10(3):205-7. PubMed ID: 26510001
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Combined Topical Anti-inflammatory and Oral Acetazolamide in the Treatment of Central Serous Chorioretinopathy.
    Wuarin R; Kakkassery V; Consigli A; Roquelaure D; Papanastasiou A; Schutz JS; Thumann G; Chronopoulos A
    Optom Vis Sci; 2019 Jul; 96(7):500-506. PubMed ID: 31274738
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy and prognostic factors of response to carbonic anhydrase inhibitors in management of cystoid macular edema in retinitis pigmentosa.
    Liew G; Moore AT; Webster AR; Michaelides M
    Invest Ophthalmol Vis Sci; 2015 Feb; 56(3):1531-6. PubMed ID: 25670491
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Subtenon triamcinolone for cystoid macular edema due to retinitis pigmentosa unresponsive to oral acetazolamide.
    Schaal Y; Hondur AM; Tezel TH
    Can J Ophthalmol; 2016 Aug; 51(4):e113-e115. PubMed ID: 27521675
    [No Abstract]   [Full Text] [Related]  

  • 5. Significant macular edema in a patient with cone dystrophy and improvement with acetazolamide treatment.
    Gelman SK; Gorin MB
    Retin Cases Brief Rep; 2014; 8(4):300-5. PubMed ID: 25372533
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intravitreal pegaptanib sodium (Macugen) for refractory cystoid macular edema in pericentral retinitis pigmentosa.
    Querques G; Prascina F; Iaculli C; Noci ND
    Int Ophthalmol; 2009 Apr; 29(2):103-7. PubMed ID: 18157710
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rebound of cystoid macular edema with continued use of acetazolamide in patients with retinitis pigmentosa.
    Apushkin MA; Fishman GA; Grover S; Janowicz MJ
    Retina; 2007 Oct; 27(8):1112-8. PubMed ID: 18040255
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The use of carbonic anhydrase inhibitors in the retreatment of cystic macular lesions in retinitis pigmentosa and X-linked retinoschisis.
    Thobani A; Fishman GA
    Retina; 2011 Feb; 31(2):312-5. PubMed ID: 20966823
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Optical coherence tomography in the diagnosis and monitoring of cystoid macular edema in patients with retinitis pigmentosa.
    Chung H; Hwang JU; Kim JG; Yoon YH
    Retina; 2006 Oct; 26(8):922-7. PubMed ID: 17031294
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment of cystoid macular edema secondary to retinitis pigmentosa: a systematic review.
    Bakthavatchalam M; Lai FHP; Rong SS; Ng DS; Brelen ME
    Surv Ophthalmol; 2018; 63(3):329-339. PubMed ID: 28987613
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Therapy Rationale for Mineralocorticoid-Receptor Antagonists, Acetazolamide and a Switch of Therapy in Nonresponders in Central Serous Chorioretinopathy.
    Rübsam A; Thieme CE; Schlomberg J; Winterhalter S; Müller B; Joussen AM; Stübiger N
    J Ocul Pharmacol Ther; 2017 Apr; 33(3):141-148. PubMed ID: 28277988
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intravitreal ranibizumab in the treatment of cystoid macular edema associated with retinitis pigmentosa.
    Artunay O; Yuzbasioglu E; Rasier R; Sengul A; Bahcecioglu H
    J Ocul Pharmacol Ther; 2009 Dec; 25(6):545-50. PubMed ID: 20028262
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A new treatment approach - Eplerenone - in central serous chorioretinopathy - Case report.
    Cioboata M; Alexandrescu C; Hopinca CA; Pienaru MC; Merticariu A; Schmitzer S
    J Med Life; 2016; 9(1):92-94. PubMed ID: 27713772
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Morning glory with serous macular detachment responds to oral acetazolamide.
    Prakash P; De Salvo G; Lotery AJ
    Eye (Lond); 2010 Nov; 24(11):1732-3. PubMed ID: 20930858
    [No Abstract]   [Full Text] [Related]  

  • 15. Retinitis pigmentosa sine pigmenti. Debut with macular oedema.
    de la Mata Pérez G; Ruiz-Moreno O; Fernández-Pérez S; Torrón Fernández-Blanco C; Pablo-Júlvez L
    Arch Soc Esp Oftalmol; 2014 Sep; 89(9):376-81. PubMed ID: 24485789
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Irvine Gass syndrome and central serous chorioretinopathy, pure coincidence or non fortuitous association? Report of three cases].
    Boulanger G; Weber M
    J Fr Ophtalmol; 2009 Oct; 32(8):566-71. PubMed ID: 19656588
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Decreased macular thickness in nonproliferative macular telangiectasia type 2 with oral carbonic anhydrase inhibitors.
    Chen JJ; Sohn EH; Folk JC; Mahajan VB; Kay CN; Boldt HC; Russell SR
    Retina; 2014 Jul; 34(7):1400-6. PubMed ID: 24451922
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Patient with recurrent central serous chorioretinopathy who developed multiple evanescent white dots and serous retinal detachment immediately following bevacizumab administration].
    Satoh S; Miyagawa Y; Mori T
    Nippon Ganka Gakkai Zasshi; 2012 Feb; 116(2):119-28. PubMed ID: 22509701
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Topical dorzolamide for the treatment of cystoid macular edema in patients with retinitis pigmentosa.
    Giuffre G
    Am J Ophthalmol; 2006 Oct; 142(4):707; author reply 707-8. PubMed ID: 17011883
    [No Abstract]   [Full Text] [Related]  

  • 20. Central serous chorioretinopathy.
    Marcuson J; Riley T
    Optometry; 2008 May; 79(5):241-51. PubMed ID: 18436164
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.